Can-Fite BioPharma CANF
NYSE CANF
$1.85 -0.04 (-2.39%)
As of: Oct 22, 2026 · 3:31 PM EDT

Can-Fite BioPharma (CANF) Net Cash Flow (2012 - 2013)

Updated

Can-Fite BioPharma's Net Cash Flow came in at $693,000 for FY2025, up 21.8% from $569,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Net Cash Flow (2012 - 2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Net Cash Flow data covers 11 years.

  • Net Cash Flow carries a five-year compound annual growth rate of -34.1% (FY2020 to FY2025).
  • The five-year range for annual Net Cash Flow is -$3.91 million (FY2021) to $1.2 million (FY2023).
  • Per Business Quant, earlier years put Net Cash Flow at $569,000 in FY2024 (-52.7%), $1.2 million in FY2023, -$1.3 million in FY2022 and -$3.91 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -3.52 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -2.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -3.94 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -4.43 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -722.00 Mn
10 Can-Fite BioPharma 1.52 Mn -18.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.20 Mn
Sep 30, 2013 -1.39 Mn
Jun 30, 2013 3.21 Mn
Dec 31, 2012 -2.76 Mn
Sep 30, 2012 -381,325.47
Jun 30, 2012 8,133.94
API Access

Can-Fite BioPharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CANF&period=max&api_key=YOUR_API_KEY